301065 Stock Overview
Engages in the research, development, production, and sale of pharmaceutical, pesticide, and other material intermediates in China and internationally. More details
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 0/6 |
Past Performance | 4/6 |
Financial Health | 6/6 |
Dividends | 2/6 |
Zhejiang Benli Technology Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥19.70 |
52 Week High | CN¥25.26 |
52 Week Low | CN¥11.81 |
Beta | 0.21 |
11 Month Change | -4.60% |
3 Month Change | 15.61% |
1 Year Change | -18.70% |
33 Year Change | -54.68% |
5 Year Change | n/a |
Change since IPO | -62.29% |
Recent News & Updates
Zhejiang Benli Technology's (SZSE:301065) Performance Is Even Better Than Its Earnings Suggest
Nov 01Recent updates
Zhejiang Benli Technology's (SZSE:301065) Performance Is Even Better Than Its Earnings Suggest
Nov 01What Zhejiang Benli Technology Co., Ltd.'s (SZSE:301065) 42% Share Price Gain Is Not Telling You
Aug 08Zhejiang Benli Technology (SZSE:301065) Will Pay A Smaller Dividend Than Last Year
Jun 19Lacklustre Performance Is Driving Zhejiang Benli Technology Co., Ltd.'s (SZSE:301065) Low P/E
Jun 07We Think You Should Be Aware Of Some Concerning Factors In Zhejiang Benli Technology's (SZSE:301065) Earnings
May 02Earnings Not Telling The Story For Zhejiang Benli Technology Co., Ltd. (SZSE:301065) After Shares Rise 30%
Mar 08Shareholder Returns
301065 | CN Pharmaceuticals | CN Market | |
---|---|---|---|
7D | -1.3% | -1.5% | -2.1% |
1Y | -18.7% | -9.4% | 2.8% |
Return vs Industry: 301065 underperformed the CN Pharmaceuticals industry which returned -9.4% over the past year.
Return vs Market: 301065 underperformed the CN Market which returned 2.8% over the past year.
Price Volatility
301065 volatility | |
---|---|
301065 Average Weekly Movement | 7.4% |
Pharmaceuticals Industry Average Movement | 7.4% |
Market Average Movement | 8.4% |
10% most volatile stocks in CN Market | 12.7% |
10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 301065 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 301065's weekly volatility (7%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2011 | 589 | Zhengjie Wu | www.benlitech.com |
Zhejiang Benli Technology Co., Ltd. engages in the research, development, production, and sale of pharmaceutical, pesticide, and other material intermediates in China and internationally. Its products include N,N-Dimethylamino ethyl acrylate; 2,4-Dichloro-5-fluorobenzoyl chloride; 2-(2,4-Dichloro-5-fluorobenzoyl)-3-cyclopropylamino acrylate ethyl ester; 1-Ethyl-7-(1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid hydrochloride; 2,4-Dichlorofluorobenzene; Methyl 3-Methoxyacrylate; Ethyl 3-ethoxyacrylate; 2,6-Dichlorofluorobenzene; 4-tert-Butylbenzoyl chloride; and 2, 4, 6-Trimethylbenzoyl chloride. The company was founded in 2011 and is based in Linhai, China.
Zhejiang Benli Technology Co., Ltd. Fundamentals Summary
301065 fundamental statistics | |
---|---|
Market cap | CN¥2.03b |
Earnings (TTM) | CN¥62.17m |
Revenue (TTM) | CN¥712.24m |
32.7x
P/E Ratio2.9x
P/S RatioIs 301065 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
301065 income statement (TTM) | |
---|---|
Revenue | CN¥712.24m |
Cost of Revenue | CN¥590.85m |
Gross Profit | CN¥121.38m |
Other Expenses | CN¥59.21m |
Earnings | CN¥62.17m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.60 |
Gross Margin | 17.04% |
Net Profit Margin | 8.73% |
Debt/Equity Ratio | 0.9% |
How did 301065 perform over the long term?
See historical performance and comparison